A long‐acting pegylated recombinant human growth hormone (Jintrolong ® ) in healthy adult subjects: Two single‐dose trials evaluating safety, tolerability and pharmacokinetics-Reference-Cited by-同舟云学术

A long‐acting pegylated recombinant human growth hormone (Jintrolong ® ) in healthy adult subjects: Two single‐dose trials evaluating safety, tolerability and pharmacokinetics

Published:2018-06-29 Issue:5 Volume:43 Page:640-646
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Guan Y.¹^ORCID,He F.¹²,Wu J.¹,Zhao L.¹,Wang X.¹,Huang L.¹,Zeng G.¹,Ren B.³,Chen J.³,Liao X.³,Ma Z.³,Chen X.³,Zhong G.¹,Huang M.¹,Zhao X.¹

Affiliation:

1. Laboratory of Drug Metabolism and PharmacokineticsSchool of Pharmaceutical SciencesSun Yat‐Sen University Guangzhou China

2. Department of PharmacyGuangzhou Women and Children's Medical Center Guangzhou China

3. The First Affiliated Hospital of Sun Yat‐Sen University Guangzhou China

Funder

Natural Science Foundation of Guangdong Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.12732

Reference19 articles.

1. Pegylated Long-Acting Human Growth Hormone Is Well-Tolerated in Healthy Subjects and Possesses a Potential Once-Weekly Pharmacokinetic and Pharmacodynamic Treatment Profile

2. Non-Compliance with Growth Hormone Treatment in Children Is Common and Impairs Linear Growth

3. Comparative pharamacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone‐deficient children;Hou L;Drug Des Devel Ther,2015

4. The Impact of PEGylation on Biological Therapies

5. Efficacy and safety of pegylated (40-kd) interferon α-2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of long-acting PEGylated growth hormone for catch-up growth in children with idiopathic short stature: a 2-year real-world retrospective cohort study;European Journal of Pediatrics;2024-08-19

2. Long-acting growth hormone in the treatment of growth hormone deficiency in children: a systematic literature review and network meta-analysis;Scientific Reports;2024-04-05

3. A Novel Peptide-Based Reversed-Phase Chromatography Platform for Mono-PEGylated Recombinant Human Growth Hormone (PEG-rhGH) Isoform Separation and Quantification;2024

4. Long-term Pegylated GH for Children With GH Deficiency: A Large, Prospective, Real-world Study;The Journal of Clinical Endocrinology & Metabolism;2023-01-21

5. Population pharmacokinetic/pharmacodynamic analysis of PEG-rhGH enhances confidence in exploring dosing schemes with longer intervals;European Journal of Pharmaceutical Sciences;2022-12